Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Frech

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Frontiers in Pharmacology|October 31, 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung DiseaseLesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, et al.
Rheumatology (Oxford, England)|August 25, 2022
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide studyKarin Melsens, Maurizio Cutolo, Dieneke Schonenberg-Meinema, et al.
JMIR Research Protocols|April 25, 2020
The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility TrialMarie-Eve Carrier, Linda Kwakkenbos, Warren R Nielson, et al.
Pilot and Feasibility Studies|February 27, 2022
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) ProgramLinda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Trials|November 28, 2021
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trialJulia Nordlund, Richard S Henry, Linda Kwakkenbos, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Best Practice & Research. Clinical Rheumatology|September 20, 2021
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SScLesley Ann Saketkoo, Tracy Frech, Cecília Varjú, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Frontiers in Pharmacology|October 31, 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung DiseaseLesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, et al.
Rheumatology (Oxford, England)|August 25, 2022
Standardized nailfold capillaroscopy in children with rheumatic diseases: a worldwide studyKarin Melsens, Maurizio Cutolo, Dieneke Schonenberg-Meinema, et al.
JMIR Research Protocols|April 25, 2020
The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility TrialMarie-Eve Carrier, Linda Kwakkenbos, Warren R Nielson, et al.
Pilot and Feasibility Studies|February 27, 2022
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) ProgramLinda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, et al.
Rheumatology (Oxford, England)|June 6, 2018
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohortsDane H Dougherty, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Trials|November 28, 2021
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trialJulia Nordlund, Richard S Henry, Linda Kwakkenbos, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Best Practice & Research. Clinical Rheumatology|September 20, 2021
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SScLesley Ann Saketkoo, Tracy Frech, Cecília Varjú, et al.
Pageof 6